» Articles » PMID: 37696641

Prevalence of Comorbidities and Its Associated Factors Among Type-2 Diabetes Patients: a Hospital-based Study in Jashore District, Bangladesh

Overview
Journal BMJ Open
Specialty General Medicine
Date 2023 Sep 11
PMID 37696641
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aimed to estimate the prevalence of comorbidity and its associated factors among Bangladeshi type-2 diabetes (T2D) patients.

Design: A hospital-based cross-sectional study.

Setting: This study was conducted in two specialised diabetic centres residing in the Jashore District of Bangladesh. A systematic random sampling procedure was applied to identify the T2D patients through a face-to-face interview.

Participants: A total of 1036 patients with T2D were included in this study. A structured questionnaire was administered to collect data on demographic, lifestyle, medical and healthcare access-related data through face-to-face and medical record reviews.

Outcome Measures And Analyses: The main outcome variable for this study was comorbidities. The prevalence of comorbidity was measured using descriptive statistics. A logistic regression model was performed to explore the factors associated with comorbidity among Bangladeshi T2D patients.

Results: The overall prevalence of comorbidity was 41.4% and the most prevalent conditions were hypertension (50.4%), retinopathy (49.6%), obesity (28.7%) and oral problem (26.2). In the regression model, the odds of comorbidities increased with gender (male: OR: 1.27, 95% CI 0.62 to 1.87), age (50-64 years: OR: 2.14, 95% CI 1.32 to 2.93; and above 65 years: OR: 2.96, 95% CI 1.83 to 4.16), occupation (unemployment: OR: 3.32, 95% CI 0.92 to 6.02 and non-manual worker: OR: 2.31, 95% CI 0.91 to 5.82), duration of diabetes (above 15 years: OR: 3.28, 95% CI 1.44 to 5.37), body mass index (obese: OR: 2.62, 95% CI 1.24 to 4.26) of patients. We also found that individuals with recommended moderate to vigorous physical activity levels (OR: 0.41, 95% CI 1.44 to 5.37) had the lowest odds of having comorbidity. Meanwhile, respondents with limited self-care practice, unaffordable medicine and financial problems had 1.82 times, 1.94 times and 1.86 times higher odds of developing comorbidities.

Conclusion: The findings could be useful in designing and implementing effective intervention strategies and programmes for people with T2D to reduce the burden of comorbidity.

Citing Articles

Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study).

Pathan M, Akter N, Mustari M, Saifuddin M, Sharifuzzaman M, Rahman M Front Endocrinol (Lausanne). 2025; 16:1542946.

PMID: 40007804 PMC: 11850251. DOI: 10.3389/fendo.2025.1542946.


Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis.

Ayoub M, Chela H, Amin N, Hunter R, Anwar J, Tahan V J Clin Med. 2025; 14(3).

PMID: 39941615 PMC: 11818918. DOI: 10.3390/jcm14030944.


Clinical Presentations and Surgical Outcomes in Patients With Nontraumatic Acute Abdominal Pain: A Prospective Analysis.

Sharma R, Lonare S, Singh S, Al-Dwlai H, Ranjan R Cureus. 2024; 16(12):e75772.

PMID: 39691411 PMC: 11651802. DOI: 10.7759/cureus.75772.


Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease.

Braha A, Timar B, Ivan V, Balica M, Daniluc L, Timar R J Clin Med. 2024; 13(19).

PMID: 39407960 PMC: 11477181. DOI: 10.3390/jcm13195901.


Evaluating Laparoscopic Sleeve Gastrectomy for Morbid Obesity: A Prospective Follow-Up Study.

Varshney A, Al Sadiq M, Kaur M, Nathawani R, Rajadhyaksha A, Gharat R Cureus. 2024; 16(6):e61630.

PMID: 38966472 PMC: 11222902. DOI: 10.7759/cureus.61630.

References
1.
Pati S, Schellevis F . Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India). PLoS One. 2017; 12(8):e0181661. PMC: 5571911. DOI: 10.1371/journal.pone.0181661. View

2.
Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

3.
Afshar S, Roderick P, Kowal P, Dimitrov B, Hill A . Multimorbidity and the inequalities of global ageing: a cross-sectional study of 28 countries using the World Health Surveys. BMC Public Health. 2015; 15:776. PMC: 4534141. DOI: 10.1186/s12889-015-2008-7. View

4.
Zhu W, Chi A, Sun Y . Physical activity among older Chinese adults living in urban and rural areas: A review. J Sport Health Sci. 2018; 5(3):281-286. PMC: 6188614. DOI: 10.1016/j.jshs.2016.07.004. View

5.
Lam A, Lepe A, Wild S, Jackson C . Diabetes comorbidities in low- and middle-income countries: An umbrella review. J Glob Health. 2021; 11:04040. PMC: 8325931. DOI: 10.7189/jogh.11.04040. View